QuidelOrtho
QDEL
$47.10
Share price
1.12%
Change (1 day)
-29.29%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total debt
Total debt on the balance sheet as of December 2024 : NZ$4.49 Billion
According to QuidelOrtho's latest financial reports the company's total debt is NZ$4.49 Billion. A company’s total debt is the sum of all current and non-current debts.
QuidelOrtho - Total debt on balance sheet (from 1996 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$4.75 B | 15.02% |
| 2023-12-31 | NZ$4.13 B | -7.89% |
| 2022-12-31 | NZ$4.48 B | 2100.38% |
| 2021-12-31 | NZ$0.20 B | 35.62% |
| 2020-12-31 | NZ$0.15 B | -9.82% |
| 2019-12-31 | NZ$0.16 B | 3.98% |
| 2018-12-31 | NZ$0.16 B | -71.34% |
| 2017-12-31 | NZ$0.55 B | 168.56% |
| 2016-12-31 | NZ$0.20 B | -3.58% |
| 2015-12-31 | NZ$0.21 B | 18.34% |
| 2014-12-31 | NZ$0.18 B | 2595.68% |
| 2013-12-31 | NZ$6.77 M | -49.09% |
| 2012-12-31 | NZ$13.3 M | -79.13% |
| 2011-12-31 | NZ$63.77 M | -38.54% |
| 2010-12-31 | NZ$0.10 B | 1014.74% |
| 2009-12-31 | NZ$9.3 M | -22.82% |
| 2008-12-31 | NZ$12.06 M | 18.99% |
| 2007-12-31 | NZ$10.13 M | -15.38% |
| 2006-12-31 | NZ$11.97 M | -44.34% |
| 2005-12-31 | NZ$21.52 M | 58.69% |
| 2004-12-31 | NZ$13.56 M | -13.54% |
| 2003-12-31 | NZ$15.68 M | -22.92% |
| 2002-12-31 | NZ$20.34 M | -38.45% |
| 2001-12-31 | NZ$33.05 M | 1.75% |
| 2000-12-31 | NZ$32.49 M | |
| 1999-03-31 | NZ$5.6 M | -3.2% |
| 1998-03-31 | NZ$5.79 M | 18.36% |
| 1997-03-31 | NZ$4.89 M | -27.12% |
| 1996-03-31 | NZ$6.71 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | NZ$51.91 M | -98.85% | 🇺🇸 USA |
 | NZ$31.45 B | 599.56% | 🇺🇸 USA |
 | NZ$52.44 B | 1,066.37% | 🇺🇸 USA |
 | NZ$24.48 M | -99.46% | 🇺🇸 USA |
 | NZ$28.75 B | 539.44% | 🇺🇸 USA |
 | NZ$7.56 B | 68.19% | 🇺🇸 USA |